161 related articles for article (PubMed ID: 30670975)
1. The Involvement of Sortilin/NTSR3 in Depression as the Progenitor of Spadin and Its Role in the Membrane Expression of TREK-1.
Mazella J; Borsotto M; Heurteaux C
Front Pharmacol; 2018; 9():1541. PubMed ID: 30670975
[TBL] [Abstract][Full Text] [Related]
2. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
[TBL] [Abstract][Full Text] [Related]
3. Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation.
Béraud-Dufour S; Devader C; Massa F; Roulot M; Coppola T; Mazella J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834811
[TBL] [Abstract][Full Text] [Related]
4. First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides.
Pietri M; Djillani A; Mazella J; Borsotto M; Heurteaux C
Neuropharmacology; 2019 Nov; 158():107715. PubMed ID: 31325429
[TBL] [Abstract][Full Text] [Related]
5. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding.
Munck Petersen C; Nielsen MS; Jacobsen C; Tauris J; Jacobsen L; Gliemann J; Moestrup SK; Madsen P
EMBO J; 1999 Feb; 18(3):595-604. PubMed ID: 9927419
[TBL] [Abstract][Full Text] [Related]
6. Altered Trek-1 Function in Sortilin Deficient Mice Results in Decreased Depressive-Like Behavior.
Moreno S; Devader CM; Pietri M; Borsotto M; Heurteaux C; Mazella J
Front Pharmacol; 2018; 9():863. PubMed ID: 30127743
[TBL] [Abstract][Full Text] [Related]
7. Shortened Spadin Analogs Display Better TREK-1 Inhibition,
Djillani A; Pietri M; Moreno S; Heurteaux C; Mazella J; Borsotto M
Front Pharmacol; 2017; 8():643. PubMed ID: 28955242
[TBL] [Abstract][Full Text] [Related]
8. Deciphering Mechanisms of Action of Sortilin/Neurotensin Receptor-3 in the Proliferation Regulation of Colorectal and Other Cancers.
Mazella J
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233189
[TBL] [Abstract][Full Text] [Related]
9. Retroinverso analogs of spadin display increased antidepressant effects.
Veyssiere J; Moha Ou Maati H; Mazella J; Gaudriault G; Moreno S; Heurteaux C; Borsotto M
Psychopharmacology (Berl); 2015 Feb; 232(3):561-74. PubMed ID: 25080852
[TBL] [Abstract][Full Text] [Related]
10. Sortilin derived propeptide regulation during adipocyte differentiation and inflammation.
Hivelin C; Mazella J; Coppola T
Biochem Biophys Res Commun; 2017 Jan; 482(1):87-92. PubMed ID: 27816451
[TBL] [Abstract][Full Text] [Related]
11. Spadin as a new antidepressant: absence of TREK-1-related side effects.
Moha Ou Maati H; Veyssiere J; Labbal F; Coppola T; Gandin C; Widmann C; Mazella J; Heurteaux C; Borsotto M
Neuropharmacology; 2012 Jan; 62(1):278-88. PubMed ID: 21807005
[TBL] [Abstract][Full Text] [Related]
12. Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients.
Devader C; Roulot M; Moréno S; Minelli A; Bortolomasi M; Congiu C; Gennarelli M; Borsotto M; Heurteaux C; Mazella J
J Affect Disord; 2017 Jan; 208():443-447. PubMed ID: 27838145
[TBL] [Abstract][Full Text] [Related]
13. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.
Borsotto M; Veyssiere J; Moha Ou Maati H; Devader C; Mazella J; Heurteaux C
Br J Pharmacol; 2015 Feb; 172(3):771-84. PubMed ID: 25263033
[TBL] [Abstract][Full Text] [Related]
14. Spadin Selectively Antagonizes Arachidonic Acid Activation of TREK-1 Channels.
Ma R; Lewis A
Front Pharmacol; 2020; 11():434. PubMed ID: 32317978
[TBL] [Abstract][Full Text] [Related]
15. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin.
Djillani A; Pietri M; Mazella J; Heurteaux C; Borsotto M
Pharmacol Ther; 2019 Feb; 194():185-198. PubMed ID: 30291907
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients.
Roulot M; Minelli A; Bortolomasi M; Maffioletti E; Gennarelli M; Borsotto M; Heurteaux C; Mazella J
Neuropsychiatr Dis Treat; 2018; 14():2307-2312. PubMed ID: 30233189
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration.
Kim JT; Napier DL; Weiss HL; Lee EY; Townsend CM; Evers BM
Neoplasia; 2018 Feb; 20(2):175-181. PubMed ID: 29272741
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin.
Devader C; Khayachi A; Veyssière J; Moha Ou Maati H; Roulot M; Moreno S; Borsotto M; Martin S; Heurteaux C; Mazella J
Br J Pharmacol; 2015 May; 172(10):2604-17. PubMed ID: 25598009
[TBL] [Abstract][Full Text] [Related]
19. Increased Brain Neurotensin and NTSR2 Lead to Weak Nociception in NTSR3/Sortilin Knockout Mice.
Devader C; Moreno S; Roulot M; Deval E; Dix T; Morales CR; Mazella J
Front Neurosci; 2016; 10():542. PubMed ID: 27932946
[TBL] [Abstract][Full Text] [Related]
20. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.
Moha ou Maati H; Bourcier-Lucas C; Veyssiere J; Kanzari A; Heurteaux C; Borsotto M; Haddjeri N; Lucas G
Brain Struct Funct; 2016 Jan; 221(1):21-37. PubMed ID: 25233810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
